Education
About Us
Working with TipRanks
Follow Us
Sotera Health (SHC)
NASDAQ:SHC
SHC Stock Chart & Stats
$19.18
-$0.21(-1.56%)
At close: 4:00 PM EST
$19.18
-$0.21(-1.56%)
Day’s Range― - ―
52-Week Range$9.53 - $19.85
Previous CloseN/A
Volume149.43K
Average Volume (3M)2.82M
Market Cap
$5.50B
Enterprise Value$6.49B
Total Cash (Recent Filing)$301.03M
Total Debt (Recent Filing)$2.28B
Price to Earnings (P/E)99.4
Beta0.95
Next Earnings
Mar 03, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding284,093,930
10 Day Avg. Volume2,319,280
30 Day Avg. Volume2,824,627
Financial Highlights & Ratios
PEG Ratio-7.84
Price to Book (P/B)9.55
Price to Sales (P/S)3.52
P/FCF Ratio85.79
Enterprise Value/Market Cap1.18
Enterprise Value/Revenue5.64
Enterprise Value/Gross Profit10.07
Enterprise Value/Ebitda15.20
Forecast
1Y Price Target
$20.42Price Target Upside6.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Competitive Moat And Cross-sellingAn integrated, best-in-class service offering drives sticky customer relationships and cross-selling opportunities that support recurring revenue, pricing power, and resilient margins.
Improved Financial ExecutionStronger execution across the income statement, balance sheet, and cash flow, together with disciplined capital spending, has lowered leverage and increases strategic flexibility for growth or acquisitions.
Legal Headwinds EasingProgress in resolving ethylene oxide litigation reduces a major overhang and can materially improve earnings power and free cash flow as residual legal risk becomes more manageable.
Bears Say
Ongoing Litigation ExposureThe potential for additional ethylene oxide lawsuits remains a material downside risk that could pressure earnings and cash flow if new claims or larger liabilities arise.
Private Equity Share OverhangPossible equity sales by private equity owners could increase share supply and place near-term downward pressure on the stock's market price.
Regulatory UncertaintyIndustry regulation could impose costly compliance requirements or operational constraints that weigh on margins and limit marketshare or outsourcing benefits.
Sotera Health News
SHC FAQ
What was Sotera Health’s price range in the past 12 months?
Sotera Health lowest stock price was $9.53 and its highest was $19.85 in the past 12 months.
What is Sotera Health’s market cap?
Sotera Health’s market cap is $5.50B.
When is Sotera Health’s upcoming earnings report date?
Sotera Health’s upcoming earnings report date is Mar 03, 2026 which is in 45 days.
How were Sotera Health’s earnings last quarter?
Sotera Health released its earnings results on Nov 04, 2025. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.218 by $0.042.
Is Sotera Health overvalued?
According to Wall Street analysts Sotera Health’s price is currently Undervalued.
Does Sotera Health pay dividends?
Sotera Health does not currently pay dividends.
What is Sotera Health’s EPS estimate?
Sotera Health’s EPS estimate is 0.24.
How many shares outstanding does Sotera Health have?
Sotera Health has 284,093,930 shares outstanding.
What happened to Sotera Health’s price movement after its last earnings report?
Sotera Health reported an EPS of $0.26 in its last earnings report, beating expectations of $0.218. Following the earnings report the stock price went down -1.084%.
Which hedge fund is a major shareholder of Sotera Health?
Currently, no hedge funds are holding shares in SHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sotera Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.42 (6.47% Upside)
$20.42 (6.47% Upside)
Blogger Sentiment
Bullish
SHC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 4.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $746.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.60%
12-Months-Change
Fundamentals
Return on Equity
10.86%
Trailing 12-Months
Asset Growth
1.19%
Trailing 12-Months
Company Description
Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
SHC Company Deck
SHC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Sotera Health's earnings call highlighted strong financial performance, particularly in revenue growth and debt reduction, alongside significant achievements like Nordion's license renewal. However, challenges remain with Nelson Labs' revenue decline and ongoing litigation in Georgia.View all SHC earnings summariesSHC Stock 12 Month Forecast
Average Price Target
$20.42
▲(6.47% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---